Dealing with the High Bleeding and Thrombosis Risks in Critically Ill Patients with Chronic Liver Disease: A Dilemma in the Clinical Practice

Jo-Nan Liao; Tze-Fan Chao

doi:10.1055/a-1792-7875

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2022; 122(06): 867-869
DOI: 10.1055/a-1792-7875

Invited Editorial Focus

Dealing with the High Bleeding and Thrombosis Risks in Critically Ill Patients with Chronic Liver Disease: A Dilemma in the Clinical Practice

Jo-Nan Liao

¹Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

²Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

³Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan

,

Tze-Fan Chao

¹Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

²Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

³Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan

› Author Affiliations

Abstract

Full Text

References

References
1 Qamar A, Vaduganathan M, Greenberger NJ, Giugliano RP. Oral anticoagulation in patients with liver disease. J Am Coll Cardiol 2018; 71 (19) 2162-2175
2 Kuo L, Chao TF, Liu CJ. et al. Liver cirrhosis in patients with atrial fibrillation: Would oral anticoagulation have a net clinical benefit for stroke prevention?. J Am Heart Assoc 2017; 6 (06) 6
3 Zanetto A, Rinder HM, Campello E. et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features. Hepatology 2020; 72 (04) 1327-1340
4 Valeriani E, Di Nisio M, Riva N. et al. Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Thromb Haemost 2021; 121 (07) 867-876
5 Werner MJM, de Kleine RHJ, de Boer MT. et al. Routine postoperative antithrombotic therapy in pediatric liver transplantation: impact on bleeding and thrombotic complications. Thromb Haemost 2020; 120 (04) 627-637
6 Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F. faculty of the 7th International Coagulation in Liver Disease. Concepts and controversies in haemostasis and thrombosis associated with liver disease: Proceedings of the 7th International Coagulation in Liver Disease conference. Thromb Haemost 2018; 118 (08) 1491-1506
7 Ow TW, Fatourou E, Rabinowich L. et al. Prevalence of bleeding and thrombosis in critically ill patients with chronic liver disease. Thromb Haemost 2022;122(06):
8 Muciño-Bermejo J, Carrillo-Esper R, Méndez-Sánchez N, Uribe M. Thrombosis and hemorrhage in the critically ill cirrhotic patients: five years retrospective prevalence study. Ann Hepatol 2015; 14 (01) 93-98
9 Cho J, Choi SM, Yu SJ. et al. Bleeding complications in critically ill patients with liver cirrhosis. Korean J Intern Med (Korean Assoc Intern Med) 2016; 31 (02) 288-295
10 Al-Dorzi HM, Tamim HM, Aldawood AS, Arabi YM. Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence. Thrombosis 2013; 2013: 807526
11 Wijarnpreecha K, Boonpheng B, Thongprayoon C, Jaruvongvanich V, Ungprasert P. The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis. Clin Res Hepatol Gastroenterol 2017; 41 (05) 525-532
12 Alonso A, Misialek JR, Amiin MA. et al. Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort. Heart 2014; 100 (19) 1511-1516
13 Targher G, Mantovani A, Pichiri I. et al. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin Sci (Lond) 2013; 125 (06) 301-309
14 Søgaard KK, Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009; 104 (01) 96-101
15 Wu H, Nguyen GC. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 2010; 8 (09) 800-805
16 Chao TF, Chiang CE, Lin YJ. et al. Evolving changes of the use of oral anticoagulants and outcomes in patients with newly diagnosed atrial fibrillation in taiwan. Circulation 2018; 138 (14) 1485-1487
17 Cheng WH, Chiang CE, Lin YJ. et al. Non-vitamin K antagonist oral anticoagulants in elderly (≥85 years) patients with newly diagnosed atrial fibrillation: changing clinical practice and outcomes for stroke prevention in a nationwide cohort study. Mayo Clin Proc 2021; 96 (01) 52-65
18 Chao TF, Joung B, Takahashi Y. et al. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary. Thromb Haemost 2022; 122 (01) 20-47
19 Chang SH, Chou IJ, Yeh YH. et al. Association between use of non-vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 2017; 318 (13) 1250-1259
20 Intagliata NM, Henry ZH, Maitland H. et al. Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation. Dig Dis Sci 2016; 61 (06) 1721-1727
21 Hum J, Shatzel JJ, Jou JH, Deloughery TG. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis. Eur J Haematol 2017; 98 (04) 393-397
22 Lee SR, Lee HJ, Choi EK. et al. Direct oral anticoagulants in patients with atrial fibrillation and liver disease. J Am Coll Cardiol 2019; 73 (25) 3295-3308
23 Chokesuwattanaskul R, Thongprayoon C, Bathini T. et al. Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: a systematic review and meta-analysis. Dig Liver Dis 2019; 51 (04) 489-495
24 Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 2017; 14 (11) 627-628
25 Romiti GF, Pastori D, Rivera-Caravaca JM. et al. Adherence to the ‘atrial fibrillation better care’ pathway in patients with atrial fibrillation: Impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost 2022; 122 (03) 406-414